My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 124

    1.

    The Dapsone hypersensitivity syndrome revisited: a potentially fatal multisystem disorder with prominent hepatopulmonary manifestations.

    Kosseifi SG, Guha B, Nassour DN, Chi DS, Krishnaswamy G.

    J Occup Med Toxicol. 2006 Jun 6;1:9.PMID: 16756657 [PubMed]Related articlesFree article

    2.

    Dapsone induced cholangitis as a part of dapsone syndrome: a case report.

    Itha S, Kumar A, Dhingra S, Choudhuri G.

    BMC Gastroenterol. 2003 Aug 11;3:21.PMID: 12911838 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Toxic epidermal necrolysis as a dermatological manifestation of drug hypersensitivity syndrome.

    Petkov T, Pehlivanov G, Grozdev I, Kavaklieva S, Tsankov N.

    Eur J Dermatol. 2007 Sep-Oct;17(5):422-7. Epub 2007 Aug 2.PMID: 17673387 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    A fatal case of drug-induced multi-organ damage in a patient with Hansen's disease: dapsone syndrome or rifampicin toxicity?

    Lau G.

    Forensic Sci Int. 1995 May 22;73(2):109-15.PMID: 7797183 [PubMed - indexed for MEDLINE]Related articles

    5.

    Complete atrioventricular block associated with dapsone therapy: a rare complication of dapsone-induced hypersensitivity syndrome.

    Zhu KJ, He FT, Jin N, Lou JX, Cheng H.

    J Clin Pharm Ther. 2009 Aug;34(4):489-92.PMID: 19583683 [PubMed - indexed for MEDLINE]Related articles

    6.

    Dapsone hypersensitivity syndrome.

    Prussick R, Shear NH.

    J Am Acad Dermatol. 1996 Aug;35(2 Pt 2):346-9.PMID: 8698924 [PubMed - indexed for MEDLINE]Related articles

    7.

    Dapsone hypersensitivity syndrome in non-leprosy patients: a retrospective study of its incidence in a tertiary referral center in Taiwan.

    Sheen YS, Chu CY, Wang SH, Tsai TF.

    J Dermatolog Treat. 2009;20(6):340-3.PMID: 19954390 [PubMed - indexed for MEDLINE]Related articles

    8.

    Dapsone hypersensitivity syndrome: a clinico-epidemiological review.

    Agrawal S, Agarwalla A.

    J Dermatol. 2005 Nov;32(11):883-9.PMID: 16361748 [PubMed - indexed for MEDLINE]Related articles

    9.

    Case reports: treatment of nevirapine-associated dress syndrome with intravenous immune globulin (IVIG).

    Fields KS, Petersen MJ, Chiao E, Tristani-Firouzi P.

    J Drugs Dermatol. 2005 Jul-Aug;4(4):510-3.PMID: 16004028 [PubMed - indexed for MEDLINE]Related articles

    10.

    Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): an update.

    Tas S, Simonart T.

    Dermatology. 2003;206(4):353-6. Review.PMID: 12771485 [PubMed - indexed for MEDLINE]Related articles

    11.

    [Drug rash with eosinophilia and systemic symptoms (DRESS) attributed to the oral skin-care supplement Imedeen]

    van Leeuwen JF, van der Hooft CS, Vos LE, Bekkenk MW, van Zuuren EJ, Stricker BH.

    Ned Tijdschr Geneeskd. 2005 Jun 11;149(24):1353-6. Dutch. PMID: 16008041 [PubMed - indexed for MEDLINE]Related articles

    12.

    Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome induced by celecoxib and anti-tuberculosis drugs.

    Lee JH, Park HK, Heo J, Kim TO, Kim GH, Kang DH, Song GA, Cho M, Kim DS, Kim HW, Lee CH.

    J Korean Med Sci. 2008 Jun;23(3):521-5.PMID: 18583892 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Dapsone hypersensitivity. The sulfone syndrome revisited.

    Tomecki KJ, Catalano CJ.

    Arch Dermatol. 1981 Jan;117(1):38-9.PMID: 6450569 [PubMed - indexed for MEDLINE]Related articles

    14.

    The variable clinical picture of drug-induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms in relation to the eliciting drug.

    Kano Y, Shiohara T.

    Immunol Allergy Clin North Am. 2009 Aug;29(3):481-501. Review.PMID: 19563993 [PubMed - indexed for MEDLINE]Related articles

    15.

    Presumed dapsone-induced drug hypersensitivity syndrome causing reversible hypersensitivity myocarditis and thyrotoxicosis.

    Teo RY, Tay YK, Tan CH, Ng V, Oh DC.

    Ann Acad Med Singapore. 2006 Nov;35(11):833-6.PMID: 17160201 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Drug rash with eosinophilia and systemic signs syndrome in a patient with multiple sclerosis.

    Caruso A, Vecchio R, Patti F, Neri S.

    Clin Ther. 2009 Mar;31(3):580-4.PMID: 19393848 [PubMed - indexed for MEDLINE]Related articles

    17.

    Piperacillin-tazobactam-induced drug hypersensitivity syndrome.

    Fahim S, Jain V, Victor G, Pierscianowski T.

    Cutis. 2006 Jun;77(6):353-7. Review.PMID: 16838767 [PubMed - indexed for MEDLINE]Related articles

    18.

    Drug-induced hypersensitivity syndrome: drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome induced by aspirin treatment of Kawasaki disease.

    Kawakami T, Fujita A, Takeuchi S, Muto S, Soma Y.

    J Am Acad Dermatol. 2009 Jan;60(1):146-9.PMID: 19103366 [PubMed - indexed for MEDLINE]Related articles

    19.

    Dress syndrome and fulminant hepatic failure induced by lamotrigine.

    Amante MF, Filippini AV, Cejas N, Lendoire J, Imventarza O, Parisi C.

    Ann Hepatol. 2009 Jan-Mar;8(1):75-7.PMID: 19221540 [PubMed - indexed for MEDLINE]Related articles

    20.

    Dapsone-induced sulfone syndrome.

    Lee KB, Nashed TB.

    Ann Pharmacother. 2003 Jul-Aug;37(7-8):1044-6.PMID: 12841817 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    You are here: NCBI > Literature > PubMed
    Write to the Help Desk